Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

Ulcerative Colitis Excellence Forum

Ulcerative Colitis
Excellence Forum
Leaders in the field sharing authoritative insights and institutional best practices.

Florian Rieder, MD
Conference Coverage
Florian Rieder, MD, on Biologic Agents in IBD Management
06/16/2023

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Florian Rieder, MD, addressed the optimal positioning of antitumor necrosis factors and anti-integrins among patients with Crohn disease and ulcerative colitis.
Florian Rieder, MD, addressed the optimal positioning of antitumor necrosis factors and anti-integrins among patients with Crohn disease and ulcerative colitis.
Florian Rieder, MD, addressed...
06/16/2023
Advances in Inflammatory Bowel Disease Network
Millie Long, MD
Conference Coverage
Millie Long, MD, Stresses Shared Decision-Making in the Treatment of UC
06/15/2023
Optimizing therapies to reach predefined goals, including biologic as well as symptomatic targets, could help achieve remission among patients with ulcerative colitis, Dr Long said at the AIBD regional meeting.
Optimizing therapies to reach predefined goals, including biologic as well as symptomatic targets, could help achieve remission among patients with ulcerative colitis, Dr Long said at the AIBD regional meeting.
Optimizing therapies to reach...
06/15/2023
Advances in Inflammatory Bowel Disease Network
Jess Allegretti
Video
Jessica Allegretti, MD, on the QUASAR Study in Ulcerative Colitis
06/13/2023
Dr Allegretti reviews the results of the phase 3 QUASAR trial of the interleukin-23 inhibitor guselkumab in ulcerative colitis.
Dr Allegretti reviews the results of the phase 3 QUASAR trial of the interleukin-23 inhibitor guselkumab in ulcerative colitis.
Dr Allegretti reviews the...
06/13/2023
Advances in Inflammatory Bowel Disease Network
Gil Y. Melmed, MD
Conference Coverage
Gil Melmed, MD, Reviews the Role of Interleukin Inhibitors in IBD
04/24/2023

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Gil Y. Melmed, MD, reviewed key efficacy and safety data for approved and emerging interleukin IL-12/23 and IL-23p19 inhibitors for the management of inflammatory bowel disease.
Gil Y. Melmed, MD, reviewed key efficacy and safety data for approved and emerging interleukin IL-12/23 and IL-23p19 inhibitors for the management of inflammatory bowel disease.
Gil Y. Melmed, MD, reviewed key...
04/24/2023
Advances in Inflammatory Bowel Disease Network
Jessica Allegretti, MD
Conference Coverage
Jessica Allegretti, MD, Reviews Integrated Care Models in IBD Management
04/21/2023
Dr Jessica Allegretti addresses the holistic approach to care of patients with inflammatory bowel disease to include active monitoring, follow-up, patient education, and tight control.
Dr Jessica Allegretti addresses the holistic approach to care of patients with inflammatory bowel disease to include active monitoring, follow-up, patient education, and tight control.
Dr Jessica Allegretti addresses...
04/21/2023
Advances in Inflammatory Bowel Disease Network
Raymond Cross, MD
Conference Coverage
Raymond Cross, MD, on S1Ps for Treatment of IBD
04/14/2023
S1Ps may work best for patients with moderate to more moderate-severe range of ulcerative colitis in the outpatient setting, particularly those earlier in their treatment journey, Dr Raymond Cross said during his presentation at the AIBD...
S1Ps may work best for patients with moderate to more moderate-severe range of ulcerative colitis in the outpatient setting, particularly those earlier in their treatment journey, Dr Raymond Cross said during his presentation at the AIBD...
S1Ps may work best for patients...
04/14/2023
Advances in Inflammatory Bowel Disease Network
Florian Rieder, MD
Conference Coverage
Florian Rieder, MD: Positioning Biologics Effectively in the Treatment of IBD
04/14/2023
Biologics can help in achieving and maintain remission among patients with Crohn disease, but is it true for patients with ulcerative colitis too? Dr Florian Rieder discussed antitumor necrosis factors and anti-integrins in the treatment of...
Biologics can help in achieving and maintain remission among patients with Crohn disease, but is it true for patients with ulcerative colitis too? Dr Florian Rieder discussed antitumor necrosis factors and anti-integrins in the treatment of...
Biologics can help in achieving...
04/14/2023
Advances in Inflammatory Bowel Disease Network
Jessica Allegretti, MD
Conference Coverage
Jessica Allegretti, MD, Reviews Top IBD Management Strategies
03/31/2023

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
A good management strategy in IBD care is one that successfully changes the disease course and improves quality of life.
A good management strategy in IBD care is one that successfully changes the disease course and improves quality of life.
A good management strategy in...
03/31/2023
Advances in Inflammatory Bowel Disease Network
Millie Long, MD
Conference Coverage
Millie Long, MD, Reviews the Management of Ulcerative Colitis
03/31/2023
Dr Millie Long reviewed the virtual explosion of new therapies for ulcerative colitis, and how to position them, at the Advances in Inflammatory Bowel Diseases regional meeting.
Dr Millie Long reviewed the virtual explosion of new therapies for ulcerative colitis, and how to position them, at the Advances in Inflammatory Bowel Diseases regional meeting.
Dr Millie Long reviewed the...
03/31/2023
Advances in Inflammatory Bowel Disease Network
Jeffrey Berinstein
Video
Jeffrey Berinstein, MD, on Using JAK Inhibitors Upfront in ASUC
03/20/2023
Dr Berinstein recaps his 'pitch' for the use of JAK inhibitors with corticosteroids to control acute severe ulcerative colitis, which he made to the "Shark Tank" panel at the Crohn's & Colitis Congress.
Dr Berinstein recaps his 'pitch' for the use of JAK inhibitors with corticosteroids to control acute severe ulcerative colitis, which he made to the "Shark Tank" panel at the Crohn's & Colitis Congress.
Dr Berinstein recaps his 'pitch'...
03/20/2023
Advances in Inflammatory Bowel Disease Network

Advertisement

Latest News

Conference Coverage
Endoscopic Management of Obstructing Pouch Twist
10/24/2012
A presentation on the first successful endoscopic management of a twisted J-pouch won both a Presidential Poster Award and ACG Case Reports Journal Award at the ACG Scientific Meeting on October 24.
A presentation on the first successful endoscopic management of a twisted J-pouch won both a Presidential Poster Award and ACG Case Reports Journal Award at the ACG Scientific Meeting on October 24.
A presentation on the first...
10/24/2012
Advances in Inflammatory Bowel Disease Network
News
Ustekinumab Shows Superior Persistance in CD Patients With Prior Biologic Use
08/26/2024
When used after a first-line agent, ustekinumab had significantly better persistence than other biologics.
When used after a first-line agent, ustekinumab had significantly better persistence than other biologics.
When used after a first-line...
08/26/2024
Advances in Inflammatory Bowel Disease Network
News
Upadacitinib Provides Rapid Response in Crohn's Disease
08/12/2024
Pooled data from induction trials showed improvement in symptoms of Crohn’s disease within a week.
Pooled data from induction trials showed improvement in symptoms of Crohn’s disease within a week.
Pooled data from induction...
08/12/2024
Advances in Inflammatory Bowel Disease Network
News
Colorectal Cancer Risk Higher Among Patients WIth PSC, With or Without IBD
07/24/2024
Extended screening and surveillance are recommended for all patients with primary sclerosing cholangitis, but those with comorbid inflammatory bowel disease are at highest risk.
Extended screening and surveillance are recommended for all patients with primary sclerosing cholangitis, but those with comorbid inflammatory bowel disease are at highest risk.
Extended screening and...
07/24/2024
Gastroenterology
News
Biomarker Study Finds ‘Clearcut’ Case for Early Advanced Therapy for CD
05/24/2024

Jolynn Tumolo

Jolynn Tumolo
Top-down therapy significantly outperforms step-up treatment for Crohn’s disease with fewer adverse events.
Top-down therapy significantly outperforms step-up treatment for Crohn’s disease with fewer adverse events.
Top-down therapy significantly...
05/24/2024
Advances in Inflammatory Bowel Disease Network
fecal calprotectin test
News
Fecal Calprotectin: Effective Marker In Understanding Progression of Crohn's Disease
05/09/2024

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Evidence shows the value of fecal calprotectin to better understand the trajectory of Crohn's disease.
Evidence shows the value of fecal calprotectin to better understand the trajectory of Crohn's disease.
Evidence shows the value of...
05/09/2024
Advances in Inflammatory Bowel Disease Network
News
Study Finds Higher-Than-Expected IBD Rates in US Black Women
05/02/2024

Jolynn Tumolo

Jolynn Tumolo
The incidence of inflammatory bowel disease was highest among Black women younger than 30 years of age.
The incidence of inflammatory bowel disease was highest among Black women younger than 30 years of age.
The incidence of inflammatory...
05/02/2024
Advances in Inflammatory Bowel Disease Network
FDA alert
FDA Alert
FDA Approves Subcutaneous Vedolizumab for Maintenance Therapy in Crohn’s Disease
04/22/2024
The US Food and Drug Administration approved a subcutaneous formulation of vedolizumab for moderate to severe Crohn's disease.
The US Food and Drug Administration approved a subcutaneous formulation of vedolizumab for moderate to severe Crohn's disease.
The US Food and Drug...
04/22/2024
Advances in Inflammatory Bowel Disease Network
Bharati Kochar
Conference Coverage
Bharati Kochar, MD, on Comparative Effectiveness in Positioning Therapies in Ulcerative Colitis
04/10/2024
Dr Bharati Kochar talks about considering the efficacy-safety relationship to avoid longstanding corticosteroid use or the use of less effective agents in biologic-exposed populations at the AIBD regional meeting in Boston.
Dr Bharati Kochar talks about considering the efficacy-safety relationship to avoid longstanding corticosteroid use or the use of less effective agents in biologic-exposed populations at the AIBD regional meeting in Boston.
Dr Bharati Kochar talks about...
04/10/2024
Advances in Inflammatory Bowel Disease Network
News
Post-Menopausal Women With IBD and Hormone Replacement Therapy
04/05/2024

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Investigators sought to determine the effects of hormone replacement therapy on disease activity among post-menopausal women with IBD.
Investigators sought to determine the effects of hormone replacement therapy on disease activity among post-menopausal women with IBD.
Investigators sought to...
04/05/2024
Advances in Inflammatory Bowel Disease Network
News
Extended Mirikizumab Induction Benefits Slower Responders in UC Trials
03/20/2024

Jolynn Tumolo

Jolynn Tumolo
LUCENT trials found that 24-week induction period generated response in half of patients.
LUCENT trials found that 24-week induction period generated response in half of patients.
LUCENT trials found that 24-week...
03/20/2024
Advances in Inflammatory Bowel Disease Network

Advertisement

Latest Podcasts

Millie Long
Video
Millie Long, MD, on Comparative Effectiveness in Ulcerative Colitis
06/24/2024
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation...
06/24/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
Siddharth Singh: AGA Guidelines on Using Biomarkers in Ulcerative Colitis
04/25/2024
In this episode of IBD Drive Time, cohost Raymond Cross, MD, talks with Siddharth Singh, MD, about the latest guidelines from the American Gastroenterological Association on caring for patients with ulcerative colitis.
In this episode of IBD Drive Time, cohost Raymond Cross, MD, talks with Siddharth Singh, MD, about the latest guidelines from the American Gastroenterological Association on caring for patients with ulcerative colitis.
In this episode of IBD Drive...
04/25/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcasts
IBD Drive Time: Corey Siegel, MD, on Caring for the Patient with Acute Severe UC
03/20/2024
In this episode of IBD Drive Time, Dr Raymond Cross and guest Dr Corey Siegel review the key issues surrounding the care of patients hospitalized due to acute severe ulcerative colitis.
In this episode of IBD Drive Time, Dr Raymond Cross and guest Dr Corey Siegel review the key issues surrounding the care of patients hospitalized due to acute severe ulcerative colitis.
In this episode of IBD Drive...
03/20/2024
Advances in Inflammatory Bowel Disease Network
Raymond Cross, MD
Video
Raymond Cross, MD: Define UC Disease Severity in Regard to Symptoms
02/26/2024
Dr Cross reviews the highlights of his presentation on recommendations for initial diagnostics and treatment in the care of the hospitalized patient with ulcerative colitis.
Dr Cross reviews the highlights of his presentation on recommendations for initial diagnostics and treatment in the care of the hospitalized patient with ulcerative colitis.
Dr Cross reviews the highlights...
02/26/2024
Advances in Inflammatory Bowel Disease Network
Raymond Cross, MD
Conference Coverage
Raymond Cross, MD, on S1Ps for Treatment of IBD
04/14/2023
S1Ps may work best for patients with moderate to more moderate-severe range of ulcerative colitis in the outpatient setting, particularly those earlier in their treatment journey, Dr Raymond Cross said during his presentation at the AIBD...
S1Ps may work best for patients with moderate to more moderate-severe range of ulcerative colitis in the outpatient setting, particularly those earlier in their treatment journey, Dr Raymond Cross said during his presentation at the AIBD...
S1Ps may work best for patients...
04/14/2023
Advances in Inflammatory Bowel Disease Network
David Hudesman
Podcast
David Hudesman, MD, on Efficacy of Tofacitinib Induction for Ulcerative Colitis
03/07/2023
Dr Hudesman reviews the findings of a post hoc analysis he and colleagues conducted to assess associations between C-reactive protein, partial Mayo score, and efficacy outcomes during tofacitinib induction.
Dr Hudesman reviews the findings of a post hoc analysis he and colleagues conducted to assess associations between C-reactive protein, partial Mayo score, and efficacy outcomes during tofacitinib induction.
Dr Hudesman reviews the findings...
03/07/2023
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Dr Corey Siegel on Acute Severe Ulcerative Colitis
11/03/2022
IBD Drive Time host Raymond Cross, MD, talks with Dr Corey Siegel about caring for patients with acute severe ulcerative colitis in the hospital and after discharge.
IBD Drive Time host Raymond Cross, MD, talks with Dr Corey Siegel about caring for patients with acute severe ulcerative colitis in the hospital and after discharge.
IBD Drive Time host Raymond...
11/03/2022
Advances in Inflammatory Bowel Disease Network
Maia Kayal
Podcast
Maia Kayal, MD, on Recycling Biologic Therapy After IPAA
11/19/2021
In this podcast, Maia Kayal, MD, from the Icahn School of Medicine at Mount Sinai in New York City, discusses her recent research into whether using the same biologic therapy before and after total proctocolectomy with ileal pouch anal...
In this podcast, Maia Kayal, MD, from the Icahn School of Medicine at Mount Sinai in New York City, discusses her recent research into whether using the same biologic therapy before and after total proctocolectomy with ileal pouch anal...
In this podcast, Maia Kayal, MD,...
11/19/2021
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Sunanda Kane, MD, on JAK Inhibitors
10/13/2021
Sunanda Kane, MD, from the Mayo Clinic and host Raymond Cross, MD, discuss JAK inhibitors in the treatment of inflammatory bowel disease in this IBD Drive Time.
Sunanda Kane, MD, from the Mayo Clinic and host Raymond Cross, MD, discuss JAK inhibitors in the treatment of inflammatory bowel disease in this IBD Drive Time.
Sunanda Kane, MD, from the Mayo...
10/13/2021
Advances in Inflammatory Bowel Disease Network
Dr Narula
Podcasts
Neeraj Narula, MD, on How Periodic Colonscopies Improve CRC Survival in Patients With UC
08/31/2021
In this podcast, Dr Narula, from McMaster University in Toronto, discusses how 2 patients with ulcerative colitis (UC) who developed advanced colorectal cancer led him to conduct research into the prognostic value of regular colonoscopy among...
In this podcast, Dr Narula, from McMaster University in Toronto, discusses how 2 patients with ulcerative colitis (UC) who developed advanced colorectal cancer led him to conduct research into the prognostic value of regular colonoscopy among...
In this podcast, Dr Narula, from...
08/31/2021
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Dr Jana Al Hashash on Diet and Nutrition in IBD Care
08/05/2024
Dr Jana Al Hashash from Mayo Clinic—Florida offers guidance on how diet can affect IBD and the best approaches to maintaining adequate nutrition, along with hosts Millie Long, MD, and Raymond Cross, MD.
Dr Jana Al Hashash from Mayo Clinic—Florida offers guidance on how diet can affect IBD and the best approaches to maintaining adequate nutrition, along with hosts Millie Long, MD, and Raymond Cross, MD.
Dr Jana Al Hashash from Mayo...
08/05/2024
Advances in Inflammatory Bowel Disease Network
Shubha Bhat
Podcast
Shubha Bhat, PharmD, on the Role of the Clinical Pharmacist in IBD
07/25/2024
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
Dr Bhat reports on the recent...
07/25/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: The Best of DDW, Part 2
07/18/2024
In part 2 of this podcast, cohost Dr Millie Long discusses her picks for the "Best of DDW" on inflammatory bowel disease with her cohost, Dr Ray Cross.
In part 2 of this podcast, cohost Dr Millie Long discusses her picks for the "Best of DDW" on inflammatory bowel disease with her cohost, Dr Ray Cross.
In part 2 of this podcast,...
07/18/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Best of DDW, Part 1
07/09/2024
In the first episode of this two-part series, Dr Raymond Cross of Mercy Medical Center reviews his top picks for the best abstracts on inflammatory bowel disease presented at this year's Digestive Disease Week with cohost Dr Millie Long of...
In the first episode of this two-part series, Dr Raymond Cross of Mercy Medical Center reviews his top picks for the best abstracts on inflammatory bowel disease presented at this year's Digestive Disease Week with cohost Dr Millie Long of...
In the first episode of this...
07/09/2024
Advances in Inflammatory Bowel Disease Network
Millie Long
Video
Millie Long, MD, on Comparative Effectiveness in Ulcerative Colitis
06/24/2024
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation...
06/24/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: The Best of ECCO With Dr Frank Farraye
06/12/2024
Dr Frank Farraye, director of the IBD Center at Mayo Jacksonville, joins IBD Drive Time hosts Millie Long, MD, and Raymond Cross, MD, to review the best of presentations on the natural history of IBD at the European Crohn's & Colitis...
Dr Frank Farraye, director of the IBD Center at Mayo Jacksonville, joins IBD Drive Time hosts Millie Long, MD, and Raymond Cross, MD, to review the best of presentations on the natural history of IBD at the European Crohn's & Colitis...
Dr Frank Farraye, director of...
06/12/2024
Advances in Inflammatory Bowel Disease Network
Rishika Chugh
Podcast
Rishika Chugh, MD: Safety of Vedolizumab and Ustekinumab in Pregnancy
05/28/2024
Dr Chugh reviews the results of a recent study of the safety of ustekinumab and vedolizumab among pregnant patients with inflammatory bowel disease.
Dr Chugh reviews the results of a recent study of the safety of ustekinumab and vedolizumab among pregnant patients with inflammatory bowel disease.
Dr Chugh reviews the results of...
05/28/2024
Advances in Inflammatory Bowel Disease Network
Noa Cleveland
Podcast
Noa Krugliak Cleveland, MD, on Intestinal Ultrasound in Clinical Practice
05/22/2024
Dr Krugliak Cleveland reviews the results of research and real-world experience in using intestinal ultrasound in clinical practice when diagnosing and monitoring inflammatory bowel disease.
Dr Krugliak Cleveland reviews the results of research and real-world experience in using intestinal ultrasound in clinical practice when diagnosing and monitoring inflammatory bowel disease.
Dr Krugliak Cleveland reviews...
05/22/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Gary Lichtenstein, MD, on the Best of ECCO
05/06/2024
IBD Drive Time continues its coverage of the European Crohn's & Colitis Organization meeting as Dr Gary Lichtenstein shares his choices on the best abstracts with host Dr Raymond Cross.
IBD Drive Time continues its coverage of the European Crohn's & Colitis Organization meeting as Dr Gary Lichtenstein shares his choices on the best abstracts with host Dr Raymond Cross.
IBD Drive Time continues its...
05/06/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
Siddharth Singh: AGA Guidelines on Using Biomarkers in Ulcerative Colitis
04/25/2024
In this episode of IBD Drive Time, cohost Raymond Cross, MD, talks with Siddharth Singh, MD, about the latest guidelines from the American Gastroenterological Association on caring for patients with ulcerative colitis.
In this episode of IBD Drive Time, cohost Raymond Cross, MD, talks with Siddharth Singh, MD, about the latest guidelines from the American Gastroenterological Association on caring for patients with ulcerative colitis.
In this episode of IBD Drive...
04/25/2024
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement